- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic Immunomodulatory Treatments for Atopic Dermatitis
Authors
Keywords
-
Journal
JAMA Dermatology
Volume 158, Issue 5, Pages 523
Publisher
American Medical Association (AMA)
Online
2022-03-16
DOI
10.1001/jamadermatol.2022.0455
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy Phase 3 trial in the United States and Canada (BREEZE-AD5)
- (2021) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis
- (2021) Joseph F. Merola et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
- (2021) Thomas Bieber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) Kristian Reich et al. LANCET
- Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
- (2021) Emma Guttman-Yassky et al. LANCET
- Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis
- (2021) Andrew Blauvelt et al. JAMA Dermatology
- Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis
- (2020) Emma Guttman-Yassky et al. JAMA Dermatology
- Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis
- (2020) Aaron M. Drucker et al. JAMA Dermatology
- Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial
- (2020) Amy S. Paller et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
- (2020) Eric L Simpson et al. LANCET
- Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus
- (2020) Kenji Kabashima et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis
- (2020) Jonathan I. Silverberg et al. JAMA Dermatology
- Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis
- (2020) Kristian Reich et al. JAMA Dermatology
- Inclusion of Older Adults in Randomized Clinical Trials for Systemic Medications for Atopic Dermatitis
- (2020) Megan Lam et al. JAMA Dermatology
- GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions
- (2019) Nancy Santesso et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis
- (2019) Susan Chan et al. JAMA Pediatrics
- Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis
- (2018) Romina Brignardello-Petersen et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Risk of infection in patients with atopic dermatitis treated with dupilumab: A meta-analysis of randomized controlled trials
- (2018) Patrick Fleming et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial
- (2018) Catherine Goujon et al. Journal of Allergy and Clinical Immunology-In Practice
- Systemic immunomodulatory treatments for atopic dermatitis: protocol for a systematic review with network meta-analysis
- (2018) Aaron Mark Drucker et al. BMJ Open
- Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review
- (2016) Su Golder et al. PLOS MEDICINE
- Unknown
- (2016) ALLERGY
- The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
- (2015) Brian Hutton et al. ANNALS OF INTERNAL MEDICINE
- Determining the Minimal Clinically Important Difference and Responsiveness of the Dermatology Life Quality Index (DLQI): Further Data
- (2015) M.K.A. Basra et al. DERMATOLOGY
- The Harmonizing Outcome Measures for Eczema (HOME) Roadmap: A Methodological Framework to Develop Core Sets of Outcome Measurements in Dermatology
- (2015) Jochen Schmitt et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Unknown
- (2015) STATISTICS IN MEDICINE
- The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials
- (2014) Jochen Schmitt et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Guidelines of care for the management of atopic dermatitis
- (2014) Robert Sidbury et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis
- (2014) M. A. Puhan et al. BMJ-British Medical Journal
- A randomized trial of methotrexate versus azathioprine for severe atopic eczema
- (2011) Mandy Elvira Schram et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
- (2010) Georgia Salanti et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Checking consistency in mixed treatment comparison meta-analysis
- (2010) S. Dias et al. STATISTICS IN MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More